WTA
IMGN

Washington Trust Advisors’s Immunogen Inc IMGN Stock Holding History

Washington Trust Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,217
Closed -$11K – 907
2022
Q3 		$11K Hold
2,217
– – ﹤0.01% 597
2022
Q2 		$10K Hold
2,217
– – ﹤0.01% 636
2022
Q1 		$11K Sell
2,217
-191
-8% -$1.06K ﹤0.01% 701
2021
Q4 		$18K Buy
+2,408
New +$15K ﹤0.01% 648

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Washington Trust Advisors's IMGN Position: Q4 2022 in Review

Washington Trust Advisors sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 2,217 shares — an estimated $11K sold.

Washington Trust Advisors first reported a position in IMGN in Q4 2021 and held it in 4 quarters. The position peaked at $18K in Q4 2021. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Washington Trust Advisors reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Washington Trust Advisors sold 2,217 Immunogen Inc shares in Q4 2022, an estimated $11K.
  • Washington Trust Advisors first reported a position in Immunogen Inc in Q4 2021 and held it in 4 quarters.
  • Washington Trust Advisors's Immunogen Inc position peaked at $18K in Q4 2021.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Washington Trust Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.